It enhances the proliferation of T-cells (your immune system's special forces), supports natural killer cell activity, and helps regulate inflammatory responses
Opportunities Expanding Use in Obesity Management The growing use of GLP-1 analogues for the treatment of obesity is one of the largest opportunities
Despite these benefits, users must remain aware of L-carnitine side effects, which, although typically mild, can vary from person to person
doi: 10.1503/cmaj.101281 Summary Keywords sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, type 2 diabetes, metformin, meta-analysis Citation Deng R, Mei K, Song T, Huang J, Wu Y, Yu P, Yan Z and Liu X (2024) First-line treatment with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetic population at low risk of cardiovascular disease: a meta-analysis
Solis-Herrera, C., Kane, M